- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01441817
Non--operative Treatment of the Medial Malleolus in bi- and Trimalleolar Ankle Fractures
September 27, 2011 updated by: Oslo University Hospital
Non--operative Treatment of the Medial Malleolus in bi- and Trimalleolar Ankle Fractures. A Randomized Controlled Trial
The purpose of this study was to determine if internal fixation of the medial malleolus is necessary following open reduction and internal fixation of the lateral and, if required, the posterior malleolus treating displaced bi-or trimalleolar ankle fractures.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Oslo, Norway, 0424
- Oslo University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with Orthopaedic Trauma Association (OTA) type 44 fractures (B2-3 and C2-3).
Exclusion Criteria:
- Patients with OTA type 43 distal tibia fractures.
- Patients with soft tissue injuries involving the medial malleolus.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Surgery
|
Internal fixation of the medial malleolus following open reduction and internal fixation of the lateral and, if required, posterior malleolus.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
American Orthopaedic Foot and Ankle Society ankle hind foot score (AOFAS)
Time Frame: Average of 42 months
|
Average of 42 months
|
|
The Olerud Molander Ankle score (OMAS)
Time Frame: Average of 42 months
|
Average of 42 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Posttraumatic osteoarthritis (OA) according to the criteria of Magnusson (stage I-IV)
Time Frame: Average of 42 months
|
Average of 42 months
|
|
|
VAS score
Time Frame: Average of 42 months
|
Pain evaluated at rest, in the morning, in the evening and during the night.
|
Average of 42 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2002
Primary Completion (Actual)
August 1, 2008
Study Completion (Actual)
August 1, 2008
Study Registration Dates
First Submitted
September 15, 2011
First Submitted That Met QC Criteria
September 27, 2011
First Posted (Estimate)
September 28, 2011
Study Record Updates
Last Update Posted (Estimate)
September 28, 2011
Last Update Submitted That Met QC Criteria
September 27, 2011
Last Verified
September 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 224-01077(REK)
- REK (Other Identifier: Regional Etisk Komite)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.